Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Par Health USA, LLC recalls Buprenorphine HCl

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Crystallization; identified as Buprenorphine free base
Products
  • Buprenorphine HCl
Where it was sold

Nationwide in the USA.

Nationwide

Units affected
46,334 units
About this recall
Buprenorphine HCl, CIII, Injection, 0.3 mg/mL, 5 x 1 mL Single Dose Vials per Carton, Rx Only, For Intramuscular or Intravenous use, Manufactured for: Endo USA, Malvern, PA 19355, NDC 42023-179-05